US Patent 9040050 Combination treatment of CD38-expressing tumors
Patent 9040050 was granted and assigned to Genmab A/S on May, 2015 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 26, 2007
0
Date of Patent
May 26, 2015
0
Patent Application Number
12442808
0
Patent Citations Received
Patent Inventor Names
Yvo Graus
0
Jan Van De Winkel
0
Judith Oprins
0
Martine Van Vugt
0
Michel De Weers
0
Ole Baadsgaard
0
Paul Parren
0
Steen Lisby
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9040050 Combination treatment of CD38-expressing tumors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
